Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Malignant Melanoma

  Free Subscription


1 Ann Surg Oncol
1 Biochem Biophys Res Commun
1 BMC Cancer
1 Br J Dermatol
1 Cancer
1 Cancer Lett
1 Cancer Res
2 Clin Cancer Res
3 J Am Acad Dermatol
1 J Immunol
4 J Invest Dermatol
2 Melanoma Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Surg Oncol

    ASO Author Reflections: Cutaneous Melanoma as Model System for the Obesity Paradox in Cancer.
    Ann Surg Oncol. 2021 Mar 21. pii: 10.1245/s10434-021-09818.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  2. FANG J, Huang X, Yang Y, Wang X, et al
    Berberine-photodynamic induced apoptosis by activating endoplasmic reticulum stress-autophagy pathway involving CHOP in human malignant melanoma cells.
    Biochem Biophys Res Commun. 2021;552:183-190.
    PubMed         Abstract available

    BMC Cancer

  3. MULDER EEAP, de Joode K, Litiere S, Ten Tije AJ, et al
    Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial.
    BMC Cancer. 2021;21:323.
    PubMed         Abstract available

    Br J Dermatol

    Divergent pathways for melanoma: what is the role of genetics?
    Br J Dermatol. 2021 Mar 25. doi: 10.1111/bjd.19887.


  5. CHRISTEN C, Belgodere L, Guillot B, Jumeau C, et al
    Access to innovation through the national early access program and clinical trials for patients with malignant melanoma.
    Cancer. 2021 Mar 25. doi: 10.1002/cncr.33492.
    PubMed         Abstract available

    Cancer Lett

  6. GRILLO E, Corsini M, Ravelli C, Zammataro L, et al
    Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependence.
    Cancer Lett. 2021;507:80-88.
    PubMed         Abstract available

    Cancer Res

  7. DE SEMIR D, Bezrookove V, Nosrati M, Dar AA, et al
    Nuclear receptor coactivator NCOA3 regulates ultraviolet radiation-induced DNA damage and melanoma susceptibility.
    Cancer Res. 2021 Mar 25. pii: 0008-5472.CAN-20-3450.
    PubMed         Abstract available

    Clin Cancer Res

    Therapeutic Escape in Galphaq-Mutant Uveal Melanoma: It's a FAK.
    Clin Cancer Res. 2021 Mar 25. pii: 1078-0432.CCR-21-0567.
    PubMed         Abstract available

  9. NAJJAR YG, McCurry D, Lin H, Lin Y, et al
    Neoadjuvant Pembrolizumab and High Dose Interferon Alfa-2b in Resectable Regionally Advanced Melanoma.
    Clin Cancer Res. 2021 Mar 22. pii: 1078-0432.CCR-20-4301.
    PubMed         Abstract available

    J Am Acad Dermatol

  10. KINSER K, Barlow CE, Leonard D, Farrell SW, et al
    Tanning bed use and depression in a preventive medicine cohort: The Cooper Center Longitudinal Study.
    J Am Acad Dermatol. 2020;83:1200-1202.

  11. YELAMOS O, Manubens E, Jain M, Chavez-Bourgeois M, et al
    Improvement of diagnostic confidence and management of equivocal skin lesions by integration of reflectance confocal microscopy in daily practice: Prospective study in 2 referral skin cancer centers.
    J Am Acad Dermatol. 2020;83:1057-1063.
    PubMed         Abstract available

  12. SHI K, Kim D, Mohan LS, Garfield EM, et al
    A retrospective cohort study of the diagnostic value of different subtypes of atypical pigment network on dermoscopy.
    J Am Acad Dermatol. 2020;83:1028-1034.
    PubMed         Abstract available

    J Immunol

  13. TUCKER CG, Mitchell JS, Martinov T, Burbach BJ, et al
    Adoptive T Cell Therapy with IL-12-Preconditioned Low-Avidity T Cells Prevents Exhaustion and Results in Enhanced T Cell Activation, Enhanced Tumor Clearance, and Decreased Risk for Autoimmunity.
    J Immunol. 2020 Jul 31. pii: jimmunol.2000007. doi: 10.4049/jimmunol.2000007.
    PubMed         Abstract available

    J Invest Dermatol

  14. GUHAN SM, Shaughnessy M, Rajadurai A, Taylor M, et al
    The molecular context of vulnerability for CDK9 suppression in triple wild-type melanoma.
    J Invest Dermatol. 2021 Mar 18. pii: S0022-202X(21)00977.
    PubMed         Abstract available

  15. PERES J, Damerell V, Chauhan J, Popovic A, et al
    TBX3 promotes melanoma migration by transcriptional activation of ID1 which prevents activation of E-cadherin by MITF.
    J Invest Dermatol. 2021 Mar 17. pii: S0022-202X(21)01001.
    PubMed         Abstract available

  16. MARCHETTI MA, Nanda JK, Mancebo SE, Dusza SW, et al
    Real-world application of a non-invasive 2-gene expression test for melanoma diagnosis.
    J Invest Dermatol. 2021 Mar 17. pii: S0022-202X(21)01018.

  17. FREUND L, Kjaer SK, Guleria S, Albieri V, et al
    Use of fertility drugs and risk of malignant melanoma: results from a large Danish population-based cohort study.
    J Invest Dermatol. 2021 Mar 16. pii: S0022-202X(21)01022.
    PubMed         Abstract available

    Melanoma Res

  18. THOMPSON JF, Saw RPM, Dalton JM, Stretch JR, et al
    Treatment of in-transit melanoma metastases using intralesional PV-10.
    Melanoma Res. 2021 Mar 18. pii: 00008390-900000000-99046.
    PubMed         Abstract available

  19. SHAH P, Punekar SR, Pavlick AC
    Response to immune checkpoint inhibitor rechallenge after high-grade immune related adverse events in patients with advanced melanoma.
    Melanoma Res. 2021 Mar 18. pii: 00008390-900000000-99045.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.